OCTOBER - 202219TECH OUTLOOKclinical trials execution by providing knowledge-based consultations that offer real value," says Karen Chu, CEO of HiRO.HiRO has extensive experience delivering accelerated commercialization pathways, powered by its ability to provide innovative end-to-end clinical trial solutions. It offers a broader service model than the traditional "full service" project management and clinical trial monitoring provider. This competency is facilitated through HiRO's proven approach that simplifies and accelerates trial processes through a network of top CROs executives and the adoption of innovative technologies.A Holistic and Tech-Driven Client Engagement ApproachHiRO begins every client engagement by engaging with the firms at the discovery stage, assisting in the in-depth evaluation of assets and datasets, and offering strategic development consultancy. By supporting the execution of early-stage tasks, the company boosts efficiencies throughout the overall drug development cycle and improves go-to-market time.HiRO fulfills its goals by relying on its experienced management team that boosts the day-to-day operations by acting as executives and sponsors to oversight the quality of projects. At the same time, it offers cutting-edge trainings to its clinical research team, improving their productivity and enabling highly collaborative engagement with customer' teams.Delivering Personalized Support for Ever-Evolving NeedsHiRO categorizes biotechs into different groups and addresses their distinct needs in a highly intuitive manner. The first category includes startups and smaller firms where most clients are at the preclinical stage, perfectly poised for HiRO to unlock efficiencies through its consultant expertise. For startups, it reviews the chemistry, manufacturing, and controls (CMC) of clinical trials, along with their protocol, and performs robust strategy development to help them choose the country best suited for their first in human study. With a host of such complete offerings in a single package, HiRO ensures a fast and cost-efficient way of achieving the groundwork as it increases the company's current and future compound value. The second category comprises of more mature clients; the ones with protocols ready to enter phase I and II. In such cases, HiRO brings its experienced project management and clinical operations teams, who leverage their vast industry, and regulatory know-how to execute and conduct clinical trials within the best time frame. Moreover, HiRO propels its experienced We cater to SMBs and multinational organizations seeking to conduct cross-border regulatory submissions or applications and clinical trials execution by providing knowledge-based consultations that offer real valueWendy Mach,CCO
< Page 9 | Page 11 >